Sort   by:  
 Page size 
MetabolomicsGNPS Revealing fatty acid heterogeneity in Staphylococcal lipids with isotope labeling and RPLC-IM-MS
Up to 80% of the fatty acids in Staphylococcus aureus membrane lipids are branched, rather than straight-chain, fatty acids. The branched fatty acids (BCFAs) may have either an even or odd number of carbons and the branch position may be at the penultimate carbon (iso) or the antepenultimate (anteis...
ORGANISM(S): Staphylococcus Aureus 
2021-05-03 | MSV000087356 | GNPS
UnknownHorizontal transfer of an adaptive chimeric photoreceptor from bryophytes to ferns.
Not available
S-EPMC4020063 | biostudies-literature
UnknownRandomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.
Not available
S-EPMC4396529 | biostudies-literature
UnknownPhase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Not available
S-EPMC8522798 | biostudies-literature
UnknownBlood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial.
Not available
S-EPMC3979302 | biostudies-literature
UnknownThe REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
Not available
S-EPMC5838871 | biostudies-literature
UnknownEffects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
Not available
S-EPMC8417806 | biostudies-literature
UnknownMeta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years.
Not available
S-EPMC5299468 | biostudies-literature
UnknownEffects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
Not available
S-EPMC6617509 | biostudies-literature
UnknownEffects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
Not available
S-EPMC7645733 | biostudies-literature
Sort   by:  
 Page size